Investors want to know whether Eli Lilly is seeing the same pricing pressures on its blockbuster weight loss drug Zepbound that Novo Nordisk experienced with its…

Shares of Walgreens closed more than 20% lower on Thursday after the company reported fiscal third-quarter earnings that fell short of expectations and slashed its full-year…